Analysts have been eager to weigh in on the Healthcare sector with new ratings on Oncolytics Biotech (ONCY – Research Report), Aveanna Healthcare Holdings (AVAH – Research Report) and Sanofi (SNYNF – Research Report).
Oncolytics Biotech (ONCY)
RBC Capital analyst Douglas Miehm assigned a Buy rating to Oncolytics Biotech yesterday and set a price target of C$6.00. The company’s shares closed last Friday at $1.17, close to its 52-week low of $0.88.
According to TipRanks.com, Miehm is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Oncolytics Biotech with a $4.63 average price target, representing a 273.4% upside. In a report issued on May 10, Maxim Group also maintained a Buy rating on the stock with a $5.00 price target.
See the top stocks recommended by analysts >>
Aveanna Healthcare Holdings (AVAH)
In a report released yesterday, Ben Hendrix from RBC Capital maintained a Hold rating on Aveanna Healthcare Holdings, with a price target of $3.00. The company’s shares closed last Friday at $2.50.
According to TipRanks.com, Hendrix is a 4-star analyst with an average return of
Aveanna Healthcare Holdings has an analyst consensus of Hold, with a price target consensus of $2.53, which is a 3.3% upside from current levels. In a report issued on May 10, Truist Financial also maintained a Hold rating on the stock.
Sanofi (SNYNF)
In a report released today, Luisa Hector from Berenberg Bank maintained a Buy rating on Sanofi, with a price target of EUR105.00. The company’s shares closed last Friday at $102.52.
According to TipRanks.com, Hector is a 4-star analyst with an average return of
Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $113.43, representing a 12.4% upside. In a report issued on May 6, UBS also maintained a Buy rating on the stock with a EUR110.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ONCY:
